Cargando…

Global incidence and prevalence of nonalcoholic fatty liver disease

Nonalcoholic fatty liver disease (NAFLD) is a leading cause of liver disease worldwide. The estimated global incidence of NAFLD is 47 cases per 1,000 population and is higher among males than females. The estimated global prevalence of NAFLD among adults is 32% and is higher among males (40%) compar...

Descripción completa

Detalles Bibliográficos
Autores principales: Teng, Margaret LP, Ng, Cheng Han, Huang, Daniel Q., Chan, Kai En, Tan, Darren JH, Lim, Wen Hui, Yang, Ju Dong, Tan, Eunice, Muthiah, Mark D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association for the Study of the Liver 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10029957/
https://www.ncbi.nlm.nih.gov/pubmed/36517002
http://dx.doi.org/10.3350/cmh.2022.0365
_version_ 1784910252262555648
author Teng, Margaret LP
Ng, Cheng Han
Huang, Daniel Q.
Chan, Kai En
Tan, Darren JH
Lim, Wen Hui
Yang, Ju Dong
Tan, Eunice
Muthiah, Mark D.
author_facet Teng, Margaret LP
Ng, Cheng Han
Huang, Daniel Q.
Chan, Kai En
Tan, Darren JH
Lim, Wen Hui
Yang, Ju Dong
Tan, Eunice
Muthiah, Mark D.
author_sort Teng, Margaret LP
collection PubMed
description Nonalcoholic fatty liver disease (NAFLD) is a leading cause of liver disease worldwide. The estimated global incidence of NAFLD is 47 cases per 1,000 population and is higher among males than females. The estimated global prevalence of NAFLD among adults is 32% and is higher among males (40%) compared to females (26%). The global prevalence of NAFLD has increased over time, from 26% in studies from 2005 or earlier to 38% in studies from 2016 or beyond. The prevalence of NAFLD varies substantially by world region, contributed by differing rates of obesity, and genetic and socioeconomic factors. The prevalence of NAFLD exceeds 40% in the Americas and South-East Asia. The prevalence of NAFLD is projected to increase significantly in multiple world regions by 2030 if current trends are left unchecked. In this review, we discuss trends in the global incidence and prevalence of NAFLD and discuss future projections.
format Online
Article
Text
id pubmed-10029957
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher The Korean Association for the Study of the Liver
record_format MEDLINE/PubMed
spelling pubmed-100299572023-03-22 Global incidence and prevalence of nonalcoholic fatty liver disease Teng, Margaret LP Ng, Cheng Han Huang, Daniel Q. Chan, Kai En Tan, Darren JH Lim, Wen Hui Yang, Ju Dong Tan, Eunice Muthiah, Mark D. Clin Mol Hepatol Review Nonalcoholic fatty liver disease (NAFLD) is a leading cause of liver disease worldwide. The estimated global incidence of NAFLD is 47 cases per 1,000 population and is higher among males than females. The estimated global prevalence of NAFLD among adults is 32% and is higher among males (40%) compared to females (26%). The global prevalence of NAFLD has increased over time, from 26% in studies from 2005 or earlier to 38% in studies from 2016 or beyond. The prevalence of NAFLD varies substantially by world region, contributed by differing rates of obesity, and genetic and socioeconomic factors. The prevalence of NAFLD exceeds 40% in the Americas and South-East Asia. The prevalence of NAFLD is projected to increase significantly in multiple world regions by 2030 if current trends are left unchecked. In this review, we discuss trends in the global incidence and prevalence of NAFLD and discuss future projections. The Korean Association for the Study of the Liver 2023-02 2022-12-14 /pmc/articles/PMC10029957/ /pubmed/36517002 http://dx.doi.org/10.3350/cmh.2022.0365 Text en Copyright © 2023 by The Korean Association for the Study of the Liver https://creativecommons.org/licenses/by-nc/3.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Teng, Margaret LP
Ng, Cheng Han
Huang, Daniel Q.
Chan, Kai En
Tan, Darren JH
Lim, Wen Hui
Yang, Ju Dong
Tan, Eunice
Muthiah, Mark D.
Global incidence and prevalence of nonalcoholic fatty liver disease
title Global incidence and prevalence of nonalcoholic fatty liver disease
title_full Global incidence and prevalence of nonalcoholic fatty liver disease
title_fullStr Global incidence and prevalence of nonalcoholic fatty liver disease
title_full_unstemmed Global incidence and prevalence of nonalcoholic fatty liver disease
title_short Global incidence and prevalence of nonalcoholic fatty liver disease
title_sort global incidence and prevalence of nonalcoholic fatty liver disease
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10029957/
https://www.ncbi.nlm.nih.gov/pubmed/36517002
http://dx.doi.org/10.3350/cmh.2022.0365
work_keys_str_mv AT tengmargaretlp globalincidenceandprevalenceofnonalcoholicfattyliverdisease
AT ngchenghan globalincidenceandprevalenceofnonalcoholicfattyliverdisease
AT huangdanielq globalincidenceandprevalenceofnonalcoholicfattyliverdisease
AT chankaien globalincidenceandprevalenceofnonalcoholicfattyliverdisease
AT tandarrenjh globalincidenceandprevalenceofnonalcoholicfattyliverdisease
AT limwenhui globalincidenceandprevalenceofnonalcoholicfattyliverdisease
AT yangjudong globalincidenceandprevalenceofnonalcoholicfattyliverdisease
AT taneunice globalincidenceandprevalenceofnonalcoholicfattyliverdisease
AT muthiahmarkd globalincidenceandprevalenceofnonalcoholicfattyliverdisease